NCT02202850 - Defining Remission With Etanercept in AS in Real Life Clinical Practice | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 12, 2014

Primary Completion Date

April 26, 2017

Study Completion Date

April 26, 2017

Conditions

Ankylosing Spondylitis

Interventions

DRUG

etanercept

etanercept 1 x 50 mg/week or 2 x 25mg/week

DRUG

etanercept

etanercept 1 x 50 mg/week or 2 x 25mg/week

Trial Locations (29)

1020

CHU Brugmann - Site Horta, Brussels

1040

CHIREC, Brussels

2800

Louisastraat 18, Mechelen

3600

Biomedical Research Institute/ Department of Rheumatology, Genk

Private Practice Rheumatology, Genk

ReumaClinic, Genk

Reumatologie Associatie, Genk

5030

Private Practice, Grand-Manil

5530

Cliniques Universitaires UCL de Mont-Godinne, Yvoir

6061

Hôpital Sainte Thérèse/ Department of Rheumatology, Montignies-sur-Sambre

8340

Rheumatology, Sijsele-Damme

8400

Rheumatology, Ostend

9000

Universitair Ziekenhuis Gent, Ghent

9160

Private Practice of Dr. Geert Ghyselen, Lokeren

9200

AZ Sint Blasius, Dendermonde

9300

ASZ Aalst, Aalst

B-9300

Algemeen Stedelijk Ziekenhuis, Aalst

Onze Lieve Vrouw Ziekenhuis Aalst, Aalst

Onze Lieve Vrouw Ziekenhuis, Aalst

B-1420

Private Practice, Braine-l'Alleud

B-1000

CHU St-Pierre, Brussels

B-5020

Private Practice, Champion

B-4400

Private Practice, Flemalles Haute

B-3600

Private Practice, Genk

B-6060

Grand Hopital de Charleroi, Gilly

Unknown

AZ Groeninge Campus Sint Maarten, Kortrijk

B-4000

CHU de Liège, Liège

B-2900

Office of Maenaut Kristien, Schoten

B-8700

Sint-Andries Ziekenhuis, Tielt